RxDoctor Payments Data

Bina Raghavan

Medical · San Jose, CANPI 1184671901

Payments from drug & device makers

$5,997in general payments, 2019–2025

Across 184 payments — averaging $32.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Amgen$688
  • GSK$439
  • CMP Pharma, Inc.$380
  • Viiv Healthcare Company$319
  • Lilly USA, LLC$312
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$5,997100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,997 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.

See all medical providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide19$26,565
JardianceEmpagliflozin22$17,924
OzempicSemaglutide12$11,444
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,233
Atorvastatin Calcium88$688
Albuterol Sulfate HfaAlbuterol Sulfate19$433
Glipizide ErGlipizide16$279
Levothyroxine Sodium24$238
Metformin Hcl ErMetformin Hcl27$220
Metformin Hcl45$185
Tamsulosin Hcl16$169
Gabapentin11$153
Losartan Potassium28$139
Amlodipine Besylate39$138
Citalopram HbrCitalopram Hydrobromide13$123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$1,589$38,00931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 medical providers in California.

Other medical in San Jose

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →